packageRetifanlimab
retifanlimab
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Retifanlimab is a PD-1-blocking monoclonal antibody used to treat cancers, including Merkel cell carcinoma, anal cancer, and squamous cell carcinoma. It is an approved anticancer medicine, with one product authorised in the European Union and other uses still under investigation.
Summary written by glm-5.3-flash from Wikidata Q117349369 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | retifanlimab |
| ATC codes: | L01FF10 |
| DrugBank: | DB15766 |
| Wikidata: | Q117349369 |
| molar mass: | 148000 g/mol (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |